Skip to main content

Advertisement

SpringerLink
Log in

Changes in bone mineral metabolism parameters, including FGF23, after discontinuing cinacalcet at kidney transplantation

  • Original Article
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Little is known about the effects of the administration of cinacalcet in dialytic patients who are scheduled for kidney transplantation, and in particular about the changes in FGF23 and other mineral metabolism parameters after surgery compared with recipients not on cinacalcet at kidney transplantation. We performed a prospective observational cohort study with recruitment of consecutive kidney transplant recipients at our institution. Patients were classified according to whether they were under treatment with cinacalcet before transplantation. Bone mineral metabolism parameters, including C-terminal FGF23, were measured at baseline, on day 15, and at 1, 3, and 6 months after transplantation. In previously cinacalcet-treated patients, cinacalcet therapy was discontinued on the day of surgery and was not restarted after transplantation. A total of 48 kidney transplant recipients, 20 on cinacalcet at surgery and 28 cinacalcet non-treated patients, completed the follow-up. Serum phosphate declined significantly in the first 15 days after transplantation with no differences between the two groups, whereas cinacalcet-treated patients showed higher FGF23 levels, although not significant. After transplantation, PTH and serum calcium were significantly higher in cinacalcet-treated patients. We conclude that patients receiving cinacalcet on dialysis presented similar serum phosphate levels but higher PTH and serum calcium levels during the initial six months after kidney transplantation than cinacalcet non-treated patients. The group previously treated with cinacalcet before transplantation showed higher FGF23 levels without significant differences, so further studies should investigate its relevance in the management of these patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. G.A. Block, K.J. Martin, A.L. de Francisco, S.A. Turner, M.M. Avram, M.G. Suranyi, G. Hercz, J. Cunningham, A.K. Abu-Alfa, P. Messa, D.W. Coyne, F. Locatelli, R.M. Cohen, P. Evenepoel, S.M. Moe, A. Fournier, J. Braun, L.C. McCary, V.J. Zani, K.A. Olson, T.B. Drüeke, W.G. Goodman, Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N. Engl. J. Med. 350, 1516 (2004)

    Article  CAS  PubMed  Google Scholar 

  2. P. Urena, S.H. Jacobson, E. Zitt, M. Vervloet, F. Malberti, N. Ashman, S. Leavey, M. Rix, I. Os, H. Saha, M. Ryba, V. Bencova, A. Baños, V. Zani, D. Fouque, Cinacalcet and achievement of the NKF/K-DOQI recommended target values for bone and mineral metabolism in renal-world clinical practice—the ECHO observational study. Nephrol. Dial. Transplant. 24, 2852 (2009)

    Article  CAS  PubMed  Google Scholar 

  3. D. Li, L. Shao, H. Zhou, W. Jiang, W. Zhang, Y. Xu, The efficacy of cinacalcet combined with conventional therapy on bone and mineral metabolism in dialysis patients with secondary hyperparathyroidism: a meta-analysis. Endocrine 43, 68–77 (2013)

    Article  CAS  PubMed  Google Scholar 

  4. S. Seilier, H. Heine, D. Fliser, Clinical relevance of FGF-23 in chronic kidney disease. Kidney Int. 76(114), S34–S42 (2009)

    Article  Google Scholar 

  5. H. Saito, K. Kusano, M. Kinosaki, H. Ito, M. Hirata, H. Segawa, K. Miyamoto, N. Fukushima, Human fibroblast growth factor-23 mutants suppress Na + -dependent phosphate co-transport activity and 1alpha,25-dihydroxyvitamin D3 production. J. Biol. Chem. 278, 2206–2211 (2003)

    Article  CAS  PubMed  Google Scholar 

  6. T. Shimada, H. Hasegawa, Y. Yamazaki, T. Muto, R. Hino, Y. Takeuchi, T. Fujita, K. Nakahara, S. Fukumoto, T. Yamashita, FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J. Bone Miner. Res. 19, 429–435 (2004)

    Article  CAS  PubMed  Google Scholar 

  7. T. Larsson, U. Nisbeth, O. Ljunggren, H. Juppner, Jonsson KB.: circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers. Kidney Int. 64, 2272–2279 (2003)

    Article  CAS  PubMed  Google Scholar 

  8. X. Barros, J.V. Torregrosa, M.J. Martinez de Osaba, G. Casals, R. Paschoalin, C.E. Duran, J.M. Campistol, Earlier decrease and less hypophosphatemia in preemptive kidney transplant recipients. Transplantation 94, 830–841 (2012)

    Article  CAS  PubMed  Google Scholar 

  9. P. Evenepoel, M. Naesens, K. Claes, D. Kuypers, Y. Vanrenterghem, Tertiary hyperphosphatoninism accentuates hypophosphatemia and suppresses calcitriol levels in renal transplant recipients. Am. J. Transplant. 7, 1193–2002 (2007)

    Article  CAS  PubMed  Google Scholar 

  10. I. Bhan, A. Shah, J. Holmes, T. Isakova, O. Gutierrez, S.M. Burnett, H. Jüppner, M. Wolf, Post-transplant hypophosphatemia: tertiary hyperphosphatoninism? Kidney Int. 70, 1486–1494 (2006)

    Article  CAS  PubMed  Google Scholar 

  11. D. Economidou, S. Dovas, A. Papagianni, P. Pateinakis, D. Memmos, FGF-23 levels before and after renal transplantation. J. Transplant. (2009). doi:10.1155/2009/379082

    PubMed Central  PubMed  Google Scholar 

  12. H. Kawarazaki, Y. Shibagaki, S. Fukumoto, R. Kido, I. Nakajima, S. Fuchinoue, T. Fujita, M. Fukagawa, S. Teraoka, The relative role of fibroblast growth factor 23 and parathyroid hormone in predicting future hypophosphatemia and hypercalcemia after living donor kidney transplantation: a 1-year prospective observational study. Nephrol. Dial. Transplant. 26, 2691–2695 (2011)

    Article  CAS  PubMed  Google Scholar 

  13. A. Trombetti, L. Richert, K. Hadaya, J.D. Graf, F.R. Herrmann, S.L. Ferrari, P.Y. Martin, R. Rizzoli, Early post-transplantation hypophosphatemia is associated with elevated FGF-23 levels. Eur. J. Endocrinol. 164, 839–847 (2001)

    Article  Google Scholar 

  14. J.B. Wetmore, L. Shiguang, R. Krebill, R. Menard, L.D. Quarles, Effects of cinacalcet and concurrent low-dose vitamin D on FGF23 levels in ESRD. Clin. J. Am. Soc. Nephrol. 5, 110–116 (2010)

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  15. M. Koizumi, H. Komaba, S. Nakanishi, A. Fujimori, M. Fukagawa, Cinacalcet treatment and serum FGF23 levels in haemodialysis patients with secondary hyperparathyroidism. Nephrol. Dial. Transplant. 27, 784–790 (2012)

    Article  CAS  PubMed  Google Scholar 

  16. P. Evenepoel, B. Sprangers, E. Lerut, B. Bammens, K. Claes, D. Kuypers, B. Meijers, Y. Vanrenterghem, Mineral metabolism in renal transplant recipients discontinuing cinacalcet at the time of transplantation: a prospective observational study. Clin. Transplant. 26, 393–402 (2012)

    Article  CAS  PubMed  Google Scholar 

  17. J.V. Torregrosa, C. Bergua, M.J. Martinez de Osaba, F. Oppenheimer, J.M. Campistol, Evolution of secondary hyperparathyroidism after kidney transplantation in patients receiving cinacalcet on dialysis. Transplant. Proc. 41, 2396–2398 (2009)

    Article  CAS  PubMed  Google Scholar 

  18. M. Meola, I. Petrucci, G. Barsotti, Long-term treatment with cinacalcet and conventional therapy reduces parathyroid hyperplasia in severe secondary hyperparathyroidism. Nephrol. Dial. Transplant. 24, 982–989 (2009)

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  19. A.L. Serra, R. Savoca, A.R. Huber, U. Hepp, A. Delsignore, M. Hersberger, R.P. Wuthrich, Effective control of persistent hyperparathyroidism with cinacalcet in renal allograft recipients. Nephrol. Dial. Transplant. 2007(22), 577–583 (2007)

    Google Scholar 

  20. P. Evenepoel, B. Van Den Bergh, M. Naesens, H. De Jonge, B. Bammens, K. Claes, D. Kuypers, Y. Vanrenterghem, Calcium metabolism in the early posttransplantation period. Clin. J. Am. Nephrol. 4, 665–672 (2009)

    Article  CAS  Google Scholar 

  21. D.A. McCarron, R.S. Muther, B. Lenfesty, W.M. Bennett, Parathyroid function in persistent hyperparathyroidism: relationship to gland size. Kidney Int. 22, 662–670 (1982)

    Article  CAS  PubMed  Google Scholar 

  22. J. Heaf, E. Tvedegaard, I.L. Kanstrup, N. Fogh-Andersen, Hyperparathyroidism and long term bone loss after renal transplantation. Clin. Transplant. 17, 268–274 (2003)

    Article  PubMed  Google Scholar 

  23. H. Boom, M.J. Mallat, J.W. de Fijter, L.C. Paul, J.A. Brujin, L.A. van Es, Calcium levels as a risk factor for delayed graft function. Transplantation 77, 868–873 (2004)

    Article  CAS  PubMed  Google Scholar 

  24. W. Gwinner, S. Suppa, M. Mengel, L. Hoy, H.H. Kreipe, H. Haller, A. Schwarz, Early calcification of renal allografts detected by protocol biopsies: causes and clinical implications. Am. J. Transplant. 5, 1934–1941 (2005)

    Article  PubMed  Google Scholar 

  25. P. Messa, C. Cafforio, C. Alfieri, Clinical impact of hypercalcemia in kidney transplant. Int. J. Nephrol. (2011). doi:10.4061/2011/906832

    PubMed Central  PubMed  Google Scholar 

  26. R.P. Paschoalin, J.V. Torregrosa, X. Barros, C.E. Duran, M. Soler, J.M. Campistol, Withdrawal of cinacalcet at the time of renal transplantation is not a risk factor for allograft calcifications in the early post transplantation period. Tranplant Proc. 44, 2379–2380 (2012)

    Article  CAS  Google Scholar 

  27. M.S. Razzaque, The FGF23_Klotho axis: endocrine regulation of phosphate homeostasis. Nat. Rev. Endocrinol. 5, 611–619 (2009)

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  28. J.L. Finch, M. Tokumoto, H. Nakamura, W. Yao, M. Shahnazari, N. Lane, E. Slatopolsky, Effect of paricalcitol and cinacalcet on serum phosphate, FGF-23, and bone in rats with chronic kidney disease. Am. J. Physiol. Renal. Physiol. 298, F1315–F1322 (2010)

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  29. T. Meir, K. Durlacher, Z. Pan, G. Amir, W.G. Richards, J. Silver, T. Naveh-Many, Parathyroid hormone activates the orphan nuclear receptor Nurr1 to induce FGF23 transcription. Kidney Int. (2014). doi:10.1038/ki.2014.215

Download references

Author information

Authors and Affiliations

  1. Nephrology and Renal Transplant Department, Hospital Clinic, Barcelona, Spain

    Xoana Barros, Raphael Paschoalin, Federico Oppenheimer & Jose V. Torregrosa

  2. Nuclear Medicine Department, Hospital Clinic, Barcelona, Spain

    David Fuster, Pilar Perlaza & Francesca Pons

  3. Department of Imaging & Laboratory (Nuclear Medicine, PET/CT Centre, Radiology, Neuroradiology, Medical Physics, Clinical Laboratory, Molecular Biology, Microbiology, Pathology), Santa Maria della Misericordia Rovigo Hospital, Via Tre Martiri 140, 45100, Rovigo, Italy

    Domenico Rubello

Authors
  1. Xoana Barros
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David Fuster
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Raphael Paschoalin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Federico Oppenheimer
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Domenico Rubello
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Pilar Perlaza
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Francesca Pons
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Jose V. Torregrosa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Domenico Rubello.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Barros, X., Fuster, D., Paschoalin, R. et al. Changes in bone mineral metabolism parameters, including FGF23, after discontinuing cinacalcet at kidney transplantation. Endocrine 49, 267–273 (2015). https://doi.org/10.1007/s12020-014-0400-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-014-0400-1

Keywords

Search

Navigation